Carter Bankshares Cash Flow Statement
NASDAQ: CAREFinanceMajor BanksUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Carter Bankshares free cash flow
In fiscal 2025, Carter Bankshares generated $39.9 million of operating cash flow and spent $8.1 million on capital expenditures. That left free cash flow of $31.8 million, a free-cash-flow margin of 156.6% of revenue. Free cash flow was up 10.4% from the prior year's $28.8 million.
Carter Bankshares returned $20.0 million to shareholders through share repurchases, equal to 63% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Carter Bankshares cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Net Income | 31.36M | 24.52M | 23.38M | 50.12M | 31.59M | -45.86M | 26.57M |
| Net Income growth (YoY) | +27.89% | +4.87% | -53.34% | +58.65% | — | -272.56% | — |
| Depreciation & Amortization | 7.86M | 7.05M | 6.25M | 6.06M | 6.23M | 6.14M | 5.33M |
| Stock-Based Compensation | 2.07M | 1.75M | 1.56M | 1.31M | 1.04M | 1.02M | 381.00K |
| Change in Working Capital | -470.00K | 3.30M | -46.00K | 635.00K | 6.99M | -24.44M | 12.32M |
| Operating Cash Flow | 39.86M | 36.94M | 46.73M | 70.79M | 77.54M | 7.70M | 38.29M |
| Capital Expenditures | -8.05M | -8.13M | -9.80M | -5.89M | -8.48M | -10.12M | -8.45M |
| Investing Cash Flow | -155.91M | -68.40M | -307.01M | -382.07M | -106.36M | -93.27M | -129.36M |
| Dividends Paid | — | — | — | 0 | 0 | -3.69M | 0 |
| Share Repurchases | -20.00M | 0 | -16.42M | -42.93M | -157.00K | 0 | 0 |
| Financing Cash Flow | 90.04M | 108.11M | 267.94M | 80.35M | 64.67M | 201.69M | -76.94M |
| Net Change in Cash | -26.01M | 76.64M | 7.66M | -230.93M | 35.86M | 116.13M | -168.01M |
| Free Cash Flow | 31.81M | 28.80M | 36.93M | 64.90M | 69.05M | -2.42M | 29.83M |
This table shows 7 annual periods of Carter Bankshares's cash flow statement, from FY 2025 back to FY 2019, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CARE's reporting calendar. What is a cash flow statement?